Skip to content
Screener

Guardian Pharmacy Services GRDN Q1 2025 earnings

Reported May 12, 2025 · After market close

Revenue$329.3MIn line
EPS$0.21Miss by $0.01
Revenue estimate$329.4M
EPS estimate$0.22

Next report

Date not yet announced

Financials

Q1 2025

Income statement

See full
Revenue$329.3M+19.6%
Gross profit$64.3M+16.8%
Operating income$13.0M+63.9%
Net income$9.4M+33.2%
EPS (diluted)$0.15—

Balance sheet

See full
Cash & equivalents$14.0M—
Total debt$28.5M—
Total equity$163.2M—
Total assets$334.0M—

Cash flow

See full
Operating cash flow$17.6M+103%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$1.35B—
Enterprise value$1.36B—
P/S1×—

Profitability

See full
Gross margin19.8%—
Net margin-8.8%—

Returns & leverage

See full
Debt / equity0.2×—
Current ratio1.1×—

Segments

By segment

See full
Corporate$329.3M+19.6%

FAQ

When did Guardian Pharmacy Services report Q1 2025 earnings?
Guardian Pharmacy Services (GRDN) reported Q1 2025 earnings on May 12, 2025 after market close.
What were Guardian Pharmacy Services's Q1 2025 revenue and EPS?
Guardian Pharmacy Services reported revenue of $329.3M and eps of $0.21 for Q1 2025.
Did Guardian Pharmacy Services beat estimates in Q1 2025?
Revenue missed the consensus estimate of $329.4M by $129.0K. EPS missed the consensus estimate of $0.22 by $0.01.
How did Guardian Pharmacy Services's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.8% from $300.0M a year earlier and eps declined 14.3% from $0.24.
Where can I find Guardian Pharmacy Services's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-117815) and the 10-Q periodic report (0001193125-25-117801) directly on SEC EDGAR. The filing index links above go to sec.gov.